First in Human Study of Ziftomenib in Relapsed or Refractory Acute Myeloid Leukemia
Kura Oncology, Inc.
Kura Oncology, Inc.
Dren Bio
Incyte Corporation
AVM Biotechnology Inc
Arovella Therapeutics Ltd
CRISPR Therapeutics
AstraZeneca
AvenCell Therapeutics, Inc.
Vironexis Biotherapeutics Inc.
Pfizer
Fate Therapeutics
Syndax Pharmaceuticals
Incyte Corporation
Allogene Therapeutics
BeOne Medicines
Ossium Health, Inc.
Ossium Health, Inc.
GeoVax, Inc.
Incyte Corporation
Adela, Inc
AstraZeneca
Acerta Pharma BV
AbbVie
First Ascent Biomedical Inc.
AbbVie
Massive Bio, Inc.
CRISPR Therapeutics
Incyte Corporation
Biotroy Therapeutics
ArQule, Inc., a subsidiary of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc. (Rahway, NJ USA)
Cogent Biosciences, Inc.
Amgen
Tempus AI
Genmab
Ono Pharmaceutical Co., Ltd.
Zhejiang DTRM Biopharma
Acerta Pharma BV
Pharmacyclics LLC.
Munich Leukemia Laboratory
Munich Leukemia Laboratory
Takara Bio Inc.
Vincerx Pharma, Inc.
Xencor, Inc.
BeiGene
Servier
GlaxoSmithKline
Cyclacel Pharmaceuticals, Inc.
Pfizer
OrphAI Therapeutics
Celgene